New diagnostic test aims to enhance treatment for respiratory infections.
- New test improves diagnosis speed
- Supports clinical decision-making
- Available in CE markets
Roche has launched the cobas ePlex Respiratory Pathogen Panel 3, a diagnostic test designed to assist clinicians in identifying respiratory infections. This new respiratory infections test allows for rapid results, enabling timely treatment decisions in patients presenting with respiratory symptoms. It is part of Roche's commitment to providing advanced diagnostic solutions in the healthcare field.
The cobas ePlex platform can detect multiple respiratory pathogens simultaneously, including viruses and bacteria, which is crucial for accurate diagnosis. By quickly identifying the cause of respiratory infections, clinicians can tailor treatment plans appropriately, potentially improving patient outcomes. The panel has received CE marking, making it available in various markets across Europe.
This innovative test is expected to streamline the diagnostic process for respiratory illnesses, facilitating better management of patient care. The cobas ePlex Respiratory Pathogen Panel 3 reinforces Roche's ongoing efforts to enhance diagnostic capabilities within clinical settings, particularly in addressing common and life-threatening respiratory infections.
